Paradigmatic shifts in the management of breast cancer

Editorial

I C Henderson. N Engl J Med. 1995.

. 1995 Apr 6;332(14):951-2.

doi: 10.1056/NEJM199504063321410.

No abstract available

Comment in

Adjuvant chemotherapy in breast cancer.
Evans RA. Evans RA. N Engl J Med. 1995 Aug 31;333(9):596-7. N Engl J Med. 1995. PMID: 7623916 No abstract available.
Parametric models of therapeutic efficacy in breast cancer.
Gamel JW, Edwards MJ. Gamel JW, et al. N Engl J Med. 1996 May 9;334(19):1270-1. doi: 10.1056/NEJM199605093341913. N Engl J Med. 1996. PMID: 8606732 No abstract available.

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.
Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Bonadonna G, et al. N Engl J Med. 1995 Apr 6;332(14):901-6. doi: 10.1056/NEJM199504063321401. N Engl J Med. 1995. PMID: 7877646 Clinical Trial.
Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer.
Jacobson JA, Danforth DN, Cowan KH, d'Angelo T, Steinberg SM, Pierce L, Lippman ME, Lichter AS, Glatstein E, Okunieff P. Jacobson JA, et al. N Engl J Med. 1995 Apr 6;332(14):907-11. doi: 10.1056/NEJM199504063321402. N Engl J Med. 1995. PMID: 7877647 Clinical Trial.